Anti-IGF-1 receptor (IGF-1R) monoclonal antibodies (mAbs) were developed for clinical use in treating advanced stage cancers 22,23,24 , including Ganitumab, which remains under investigation as a combination therapy in clinical trials targeting Rhabdomyosarcoma (NCT03041701) and Ewing Sarcoma (NCT02306161), for which it recently received orphan drug status
Best before end, batch number (on the upper part of the packing)
Ideally, use in conjunction with an active nootropic compound
While the recommended daily dose of creatine consumed in the form of a supplement is 3-5g
Xenobiotic metabolism by glutathione S-transferase in gill of fish from Arabian Gulf
High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial